View Press Releases
-
Owkin Unveils AI-Driven Oncology and Immunology Pipeline, In-Licenses Best-in-Class Asset OKN4395
Today, Owkin has unveiled its precision AI drug pipeline in oncology & immunology. To accelerate time-to-patient impact, Owkin has in-licensed OKN4395, a highly selective and potent EP2/4 dual antagonist from Idorsia that will enter Phase 1 trials in early 2025.
May 22, 2024
-
Unraveling the Mysteries of Protein Lipidation with Creative Proteomics
-
Record numbers expected at CPHI & PMEC China 2024 as Asian markets boom
Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors
May 22, 2024
-
Qlucore releases unique AI-based solution in the field of lung cancer subtyping
Qlucore, listed on Nasdaq First North, can now release a new version of Qlucore Insights specifically designed for the lung cancer field, with the capability to classify primary lung samples as well as metastatic lesions. The lung cancer model is being developed with Heidelberg University Hospital, supported by a Eurostars Joint European Programme grant.
May 22, 2024
-
Protheragen-ING Lab, a Trustworthy GLP Service Provider, Unveils Its Cutting-Edge Medical Device Services
-
Vaxess Announces $12M in Funding
-
CD Formulation Provides Genotoxic Impurity Testing Services to Detect and Evaluate the Potential of GIs for API and Drug Substances
-
Cresset appoints new Non-Executive Director
-
DrFirst Announces 2024 Healthiverse Heroes Award Winners
DrFirst Announces 2024 Healthiverse Heroes Award Winners https://www.prnewswire.com/news-releases/drfirst-announces-2024-healthiverse-heroes-award-winners-302150945.html?tc=eml_cleartime
May 20, 2024
-
CG Life Acquires Berry & Company Public Relations, Further Expanding Strategic Communications Services for BioPharma and Healthcare
CG Life, a science-first, tech-enabled agency, acquires Berry & Company Public Relations. The acquisition significantly expands the range of CG Life communications expertise and services to support clients in the biopharma and medical sectors.
May 20, 2024
-
Huateng Pharma Introduces Piroctone Olamine: A New Solution for Fungal Infections and Dandruff Control
Huateng Pharma, a leader in innovative pharmaceutical solutions, is excited to announce the launch of its latest product, Piroctone Olamine (CAS No. 68890-66-4).
May 19, 2024
-
Biopharma PEG to Showcase Innovative PEG Derivatives at BIO 2024 in San Diego
Biopharma PEG, a renowned leader in the development and supply of high-quality polyethylene glycol (PEG) derivatives, is pleased to announce its participation in the BIO International Convention 2024. The event will take place from June 3-6, 2024, at the San Diego Convention Center, and attendees can visit Biopharma PEG at Booth 5102.
May 19, 2024
-
Phenomix Sciences Raises $7.8M in Funding to Accelerate Adoption of Obesity Precision Medicine
Precision medicine biotechnology company for obesity secures additional institutional capital from prominent industry leaders to expand the use of its novel phenotyping test and advance clinical research in weight loss treatment.
May 15, 2024
-
IntelliGuard Appoints Seasoned Leader as New Chief Product Officer for Enhanced Healthcare Solutions
Rob Sobie to support IntelliGuard’s ongoing innovation to track, trace, and improve safety in medication inventory
May 14, 2024
-
Lindus Health Announces Cosmetics Clinical Trial with Acinonyx Bio to Evaluate an Alternative to Benzoyl Peroxide for Inflammatory Acne
https://www.prnewswire.com/news-releases/lindus-health-announces-cosmetics-clinical-trial-with-acinonyx-bio-to-evaluate-an-alternative-to-benzoyl-peroxide-for-inflammatory-acne-302146936.html?tc=eml_cleartime
May 15, 2024
-
MDClone Earns Fourth Consecutive "Best Healthcare Big Data Platform" Award from MedTech Breakthrough
https://www.prnewswire.com/news-releases/mdclone-earns-fourth-consecutive-best-healthcare-big-data-platform-award-from-medtech-breakthrough-302147956.html?tc=eml_cleartime
May 15, 2024
-
Prebiotic Fibre Supplement Significantly Reduces Risk of Developing Type 2 Diabetes, UK Study Finds
Today, The British Journal of Nutrition published a study that found the consumption of a daily prebiotic fibre supplement helped to improve insulin sensitivity and other important health markers in patients with pre-diabetes
May 15, 2024
-
Alfa Chemistry Debuts Shape Memory Alloys, Nitinol SMAs, and 3D Printing Alloys
-
Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards
Mural Health Named “Most Innovative Start-up” at the 2024 Citeline Awards
May 14, 2024
-
Icosagen and Lead Discovery Center Announce Collaboration to Discover Novel Monoclonal Antibodies
Icosagen announces a strategic partnership on selected projects with Lead Discovery Center GmbH (LDC) to discover novel monoclonal antibodies.
May 14, 2024